(Proven left to proper) Picture of the Fathom Pedicle-Primarily based Retractor System and the Lattus Lateral Entry System for minimally invasive spine procedures. (Picture: Enterprise Wire)
LEWISVILLE, Texas, April 25, 2023–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a number one international spine and orthopedics firm, right this moment introduced the complete industrial launch of two entry retractor programs to assist surgeons throughout minimally invasive spine (MIS) procedures. The Lattus™ Lateral Entry System and the Fathom™ Pedicle-Primarily based Retractor System broaden the Firm’s providing of entry options to handle the estimated $1.8 billion MIS surgical procedure market.
The Lattus Lateral Entry System is designed for ease of use and flexibility. The novel, impartial blade retraction energy, with “down-and-out” splay characteristic, supplies entry to difficult anatomy. With a full suite of instrumentation that facilitates use of the Firm’s revolutionary WaveForm® L and Regatta® NanoMetalene® interbody gadgets, the Lattus retractor system optimizes the lateral process.
“The Lattus Lateral Entry System addresses 5 necessary areas of lateral spine surgical procedure: entry to the spine, preparation or removing of the disc, interbody placement, plate fixation, and simple integration with intraoperative monitoring by way of a sophisticated interface,” stated Dr. James Lynch, a spinal neurosurgeon and president of the Swift Institute in Reno, NV. “This improved lateral portfolio optimizes every procedural factor, from entry to fusion, in order that I can effectively and successfully deal with every affected person’s distinctive spinal situation.”
Orthofix has additionally initiated the complete industrial launch of the Fathom Pedicle-Primarily based Retractor System. With three factors of lively telescoping blade fixation, the Fathom Retractor permits the surgeon to regulate the exact size of every blade and dial in a custom-made lateral to medial tilt, offering a inflexible assemble to handle every affected person’s particular anatomy. Fathom additionally permits a reproducible surgical workflow, enhances visualization with minimal gentle tissue disruption, and enhances the entire TLIF procedural options provided by the Firm.
“Fathom is the primary and solely pedicle-based retractor to supply repeatedly telescoping cranial/caudal blades and lively management to shorten or prolong the size of the medial blade in situ,” said Dr. Justin Kubeck, orthopedic spine surgeon at Monmouth Medical Middle in Lengthy Department, NJ. “With its providing of modular elements, the Fathom Retractor affords me the flexibility to carry out a minimally invasive TLIF surgical procedure with retractor placement custom-made to every affected person not like the rest presently available on the market.”
“We’re happy to supply two actually market differentiating entry programs,” stated Kevin Kenny, President of Orthofix World Backbone. “The Lattus Lateral Entry System paired with our revolutionary WaveForm® 3D printed interbodies combine seamlessly into our lateral entry procedural answer. Likewise, the Fathom Pedicle-Primarily based Retractor System integrates with our Mariner® MIS pedicle screw system and the 7D FLASH™ enabling expertise platform to fulfill surgeon’s wants and drastically expands our means to supply full procedural options within the OR.”
About Orthofix
The newly merged Orthofix-SeaSpine group is a number one international spine and orthopedics firm with a complete portfolio of biologics, revolutionary spinal {hardware}, bone progress therapies, specialised orthopedic options and a number one surgical navigation system. Its merchandise are distributed in roughly 68 nations worldwide.
The Firm is headquartered in Lewisville, Texas and has major workplaces in Carlsbad, CA, with a give attention to spine and biologics product innovation and surgeon training, and Verona, Italy, with an emphasis on product innovation, manufacturing, and medical training for orthopedics. The mixed firm’s international R&D, industrial and manufacturing footprint additionally contains services and workplaces in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Department, MS, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil.
Ahead-Wanting Statements
This information launch could embody forward-looking statements inside the that means of Part 21E of the Securities Alternate Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended. In some instances, you’ll be able to establish forward-looking statements by terminology reminiscent of “could,” “will,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “initiatives,” “intends,” “predicts,” “potential,” “proceed” or different comparable terminology. Orthofix cautions you that statements included on this information launch that aren’t an outline of historic info are forward-looking statements which might be primarily based on the Firm’s present expectations and assumptions. Every forward-looking assertion contained on this information launch is topic to dangers and uncertainties that might trigger precise outcomes to vary materially from these expressed or implied by such assertion. Relevant dangers and uncertainties embody, amongst others: the of newly launched merchandise to carry out as designed and meant and to fulfill the wants of surgeons and sufferers, together with on account of the shortage of strong scientific validation; and the dangers recognized underneath the heading “Danger Elements” in Orthofix Medical Inc.’s Annual Report on Kind 10-Ok for the fiscal yr ended December 31, 2022, which was filed with the Securities and Alternate Fee (SEC) on March 6, 2023. The Firm’s public filings with the Securities and Alternate Fee can be found at www.sec.gov. You might be cautioned to not place undue reliance on forward-looking statements, which converse solely as of the date when made. Orthofix doesn’t intend to revise or replace any forward-looking assertion set forth on this information launch to mirror occasions or circumstances arising after the date hereof, besides as could also be required by regulation.
Contacts
Alexa Huerta
Investor Relations
Tel 214 937 3190
alexahuerta@orthofix.com
Denise Landry
Media Relations
Tel 214 937 2529
deniselandry@orthofix.com
Discussion about this post